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In the current study, it has been demonstrated that PEG-grafted PEI mediated transgene 
expression without attenuation after repeated intrathecal dosing was administrated, even 
in those rats injected three times, with a 2-week interval between two continuous 
injections. Meanwhile, extent of PEGylation upon CNS gene transfer was further 
investigated. It showed that an improved in vivo transgene expression was mediated by a 
lower degree of PEG grafting. Though the low degree of PEGylation may be insufficient 
to enhance the biocompatibility of the polycation, it still helps to reduce the aggregation 
of polymer DNA complexes, minimize the interaction of the complexes with serum 
proteins, countering inhibitory effects of serum to gene transfer and consequently 
enhance the transgene expression. A low level of PEGylation, without compromising 
gene transfer efficiency, may also be useful in polymer conjugation of biologically active 
molecules, where PEG is often used a spacer. One potential application of such a 
bioconjugation is targeted gene delivery in vivo.     
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1.1       The Most Straight-Forward Way: Naked DNA Gene Delivery 
 
 
The most apparent approach among non-viral delivery is direct gene transfer with naked 
plasmid DNA. Delivery of naked DNA by intra-muscular injection has achieved efficient 
expression in hepatocytes (Wolff et al., 1997). Inspired by the successful trial, there has 
been an intense interest in generating antiviral immune response by intra-muscular 
injection of a viral antigen-encoding plasmid. These immune responses are capable 
enough to protect animals from a wide variety of live infectious agents.  This finding 
subsequently facilitates the development of a new class of therapeutic agents known as  
DNA vaccines. This mechanism of DNA uptake by muscles is only tentatively explained 
and so far it has precluded the rational design of improvements of the efficiency (Budker 
et al., 2000).  
However, for naked DNA gene delivery, the route of injection or administration 
could affect the level of gene expression. For example, according to Wolffs finding 
(1997), direct injection of naked plasmid DNA into muscle resulted in low expression. 
However, rapid injection of plasmid DNA in a large volume (1.5 to 3.0ml) through the 
portal or tail vein can result in high level of gene expression in mice, particularly in the 
liver (Liu et al., 1999). The level of gene expression was also found to be close or even 
higher than that achieved by the intravenous administration of adenoviral vectors. 
Meanwhile, efforts to develop more efficient gene transfer via naked DNA have 
been seen in approaches like gene gun and electroporation (Yang et al., 1990; Rols et al., 
1998). These novel techniques render DNA to directly penetrate the cell membrane and 
circumvent endosome/lysosome, thus avoiding enzymatic degradation. Particularly, 
direct access of DNA to the nucleus is achieved via gene gun method. It has been shown
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that injection of plasmid DNA via intra-muscular delivery followed by electroporation 
gives rise to a significant level of gene expression (Rizzuto et al., 1999). 
 
1.2  PEI (Polyethylenimine): Synthesis, Structure and Molecular Species  
 
PEI is a well-known polymer and has been widely applied in processes such as paper 
production, water purification and shampoo manufacturing.  Typically, two forms of PEI, 
branched and linear, are in use. The branched form is synthesized by acid-catalyzed 
polymerization of azridine monomers and the linear one can be produced by a similar 
process that performs at a lower temperature (Godbey et al., 1999d). 
Due to their ethylamine-repeating units, these polymers present unique attribute of 
high water solubility. In addition, their high cationic charge density allows efficient DNA 
condensation via electrostatic interactions of the polycation with negatively charged 
phosphate groups of DNA. With regard to the protonation versus pH profile of PEI, at 
physiological pH only one fifth to sixth amino nitrogens are protonated (Suh et al., 1994). 
Electrostatic interactions of nucleic acid and PEI will slightly change the protonation 
profile of PEI, but still only one second to third of nitrogens will be protonated at 
physiological pH. Thereby, different from polymers like polylysine, PEI has a high 
buffering capacity over a very broad pH range (Boussif et al., 1995). There are PEIs of 
various molecular weights (e.g. 700Da, 2, 25, 50, 70, 800kDa) provided by various 
manufacturers, as well as several PEI derivatives such as ethoxylated PEI or 
epichlorohydrin-modified PEI (Boussif et al., 1996). PEI-mediated gene transfer involves 
condensation of DNA into compact particles, uptake into the cells, release from the 
endosomal compartment into the cytoplasm and DNAs entry into the nucleus. In the next
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few sections, they will be discussed in details. 
 
1.2.1  Formation of DNA/Polycation Nanoparticles   
  
As discussed in the former section, the basis for polycation-mediated gene delivery is 
electrostatic interactions of the polycation with the negatively charged phosphate groups 
of DNA. Therefore, formation of DNA/polycation nanoparticles is a function of the 
cation-to-anion ratio, like the PEI nitrogen-to-DNA phosphate (N/P) ratio. Formation of 
nanoparticles provides a shield for DNA, thus protecting DNA from degradation by 
nucleases. In previous studies, PEI had been shown to assist in buffering the pH changes 
in endo/lysosomes resulting in inactivation of enzymes such as Dnase 2, which hence 
harbors the plasmid from enzymatic attack (Godbey et al., 2000). This finding reveals 
that transfection will be more effective when the plasmid is condensed by PEI, thus 
leading to higher expression levels when using PEI/DNA complex in contrast to naked 
DNA injection alone. The formed nanoparticles are then up-taken by the cells via natural 
processes such as absorptive endocytosis, pinocytosis and phagocytosis. 
 At N/P ratios of 2-3, complete condensation of DNA seems to happen with 
formation of neutral particles. However, the problem with the complex neutrality is the 
possibility of particle aggregation. Small-sized particles are usually formed only at higher 
polycation/DNA ratios, i.e. N/P ratios, giving rise to complexes with a strong positive net 
charge. Evidences from some studies also showed that the shape and size of the 
polycation/DNA complexes, which affects the transfection efficiency, also relies on 
parameters such as DNA condensation, the kinetics of mixture and the sequence of 
addition of polycation or DNA (Godbey et al., 1999a, c; Tang et al., 1997). For example,
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according to Boussifs work, when the polymer was applied to the plasmid in a dropwise 
manner, the resultant polyplexes manifested ten-fold higher transfection efficiency in 
vitro compared to those achieved by applying the DNA to the polymer (Boussif et al., 
1995; Boussif et al., 1996). On the other hand, in another recent study, it has been shown 
that efficient delivery of plasmid DNA complexed by PEI contains a significant portion 
of free PEI. Ultrafiltration could be used to purify PEI/DNA complexes (Sagara et al., 
2002). However, the calculation of N/P ratios remains to be resolved. 
 
1.2.2  Cellular Mechanisms for Uptake of the PEI/DNA Complexes 
 
As discussed, prior to pinocytosis or endocytosis (also known as non-specific absorptive 
endocytosis) the positively charged PEI/DNA nanoparticles binds negatively charged cell 
membrane through superficial electrostatic interaction. These positive nanoparticles had 
also been revealed to bind to sulfated proteoglycans on the cell membrane (Mislick et al., 
1996). Recently, some studies suggest that interactions with proteoglycans may be 
essential for the following process of internalization of the complexes (Uyechi et al., 
1996). 
 
1.2.3  Endosomal Escape 
 
The DNA/polycation nanoparticles are still shielded from the cytoplasm by a lipid bilayer 
when they are taken up by endosomes. In normal conditions, the endocytosed complexes 
are usually doomed to degradation by lysosomes through normal cellular trafficking. This 
is the major hurdle for gene delivery of polycation such as polylysine. 
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However, evidences from some studies also showed that the addition of chloroquine or 
glycerol could significantly enhance the transfection efficacy in vitro. These two 
chemicals may intervene lysosomal degradation and thus facilitate escape of DNA into 
the cytoplasm (Cotten et al., 1993). 
Up to now, only a few polycations show high transfection potential without the 
assistance of endosomolytic agents. PEI, for one, reveals the highest charge density and a 
high intrinsic endosomolytic activity conferred by its strong buffering capacity in a wide 
range of pH (Boussif et al., 1996). At physiological pH PEI is only partially protonated. 
When it comes to acidification in the endosomes, PEI is considered to function as a 
proton sponge, which subsequently provokes the passive chloride ion movement. The 
accumulation of the proton and chloride ions will end up swelling as a result of osmosis. 
This event will then trigger the rupture of the endosomes, releasing the PEI/DNA 
complexes into the cytosol (Boussif et al., 1995; Boussif et al., 1996). This process 
accounts for high gene transfection attained with PEI even in the absence of 
endosomolytic agents like chloroquine. 
However, the PEI/DNA particle size has some effect upon the osmolytic 
endosomolysis feature of PEI. It was shown that small PEI (800Da) or PEI (25kDa)/DNA 
complexes formed in water have lower transfection efficiency as compared to bigger 
particles formed at higher ionic strength. Interestingly, chloroquine assisted in enhancing 
transfection efficacy of smaller PEI complexes, but not their larger counterparts (Godbey 
et al., 1999c; Ogris et al., 1998). 
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1.2.4 Nuclear Entry and Complex Disassembly  
 
In the process of nuclear entry of PEI/DNA complexes, the complexes first migrate into 
the cytoplasm and later pass through the nuclear membrane. However, the exact 
underlying mechanisms for this process are still unknown. Indeed, one of the major 
barriers for efficient non-viral gene delivery is nuclear transport. The trafficking of the 
complexes through cytoplasm and the nucleus is poorly understood but has been shown 
to be inefficient in polycation condensed DNA. However, recent studies that used 
microinjection of DNA complexes into the cytoplasm or exogenous administration of 
PEI/DNA complexes indicated that PEI could have some intrinsic nuclear targeting 
activity. This polymer also assists in shielding DNA from nucleases found in the cytosol, 
thus enhances the possibilities of the migration of the complexes to the nucleus (Pollard 
et al., 2001). 
Likewise, the cellular events underlying the passage of the complexes through  
nuclear membrane are poorly understood. However, detection of intact PEI/DNA 
complexes in the nucleus suggests that it is not prerequisite for the PEI and DNA to be 
separated prior to nuclear entry. The final stage in transgene expression includes the 
disassembly of the complexes (Godbey et al., 1999d). This enables transcription 
apparatus to access DNA efficiently. Reasonably, premature degradation of DNA and 
hence low efficacy of gene delivery will follow if disassembly of the complexes comes 
too early. On the other hand, a belated or insufficient assembly will not allow efficient 
transgene expression either. 
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1.3 Advantages and Disadvantages of PEI-Mediated Gene Delivery  
 
Whether in vitro or in vivo, PEI has revealed high transfection efficacy. It was also shown 
that PEI can also facilitate migration of complexes by retrograde axonal transport to 
neuronal cell bodies after being internalised by nerve terminals in the muscle (Wang et 
al., 2001). Specifically, PEI may mediate DNA transfection in terminally differentiated 
non-dividing neurons. Studies revealed that transgene expression levels were higher with 
the PEI/DNA complexes than those obtained with HIV-derived vector and within the 
same range as that achieved with adenoviral vectors (Abdallah et al., 1996). 
With regard to its safety, PEI did not provoke apparent inflammatory responses or 
alterations indicated by glial fibrillary acidic protein (GFAP) immunoactivity in the brain 
stem after tongue injection in mice (Lemkine et al., 2002). For PEI, its lower risk of 
immunological complications is attributed to its non-viral nature. In terms of viral 
vectors, their efficiency may be undermined when high titers are produced against them 
as a result of pre-exposure to the viruses in some patients (Lachmann et al., 1997). 
Consequently, repeated administration of viral vectors was risky and ineffective 
considering pre-existing immune response or an enhanced immune response to the 
vectors following initial inoculation (Yang et al., 1995). At this point, repetitive injection 
of PEI-mediated delivery may reduce this risk (Oh et al., 2001). 
However, significant transgene expression mediated by PEI only persisted for two 
weeks in contrast to 30 days and 6 months for adenovirus and herpes simplex virus 
vectors respectively. Another problem is non-specific targeting when using PEI/DNA 
complexes. This is caused by excess positive charge contributed by the PEI. As discussed
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previously, to condense DNA and to bind the cell membrane, the PEI has to be used a bit 
more than what is used to neutralize negative charge of DNA. On the other hand, 
positively charged DNA/polycation complexes, without guidance of specific ligands, can 
also interact with blood components via non-specific electrostatic interactions and this 
can be illustrated by the aggregation of erythrocytes (Oh et al., 2001). 
Special binding of complexes to a receptor will not be possible unless a cell 
binding ligand such as transferrin is incorporated into the complexes. Meanwhile, non-
specific interactions with blood components and non-target cells are still possible. 
Masking the surface by PEGylation, allowing specific binding to the target provided that 
the ligand is not shielded or affected by the PEG coating, however can block these non-
specific interactions (Ogris et al., 1999). The next section is a further discussion on PEG. 
 
1.4 Repeated Injection Using Non-viral Polymeric Vectors for Prolonged Gene 
Expression 
 
A major hurdle to non-viral gene therapy is the transient expression nature of plasmid 
DNA. To address this issue, repeated injections would be required to maintain efficient 
long-term expression of therapeutic genes. Several research groups have applied this 
strategy in peripheral organs by either repetitive intravenous or repetitive intrathracheal 
administration (Li et al., 1999; Meyer et al., 2000; Jenkins et al., 2000). For the CNS, its 
specific traits including limited access caused by the skull and the blood-brain barrier and 
high vulnerability to injury impose formidable barriers to safe repeat gene transfer. 
Meanwhile, the commonly used transfer routes, like direct injection into the brain
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and spinal cord tissue, are highly invasive and not practical in a repeat dosing. To attain 
repeat CNS delivery, a cannula was implanted connecting to a subcutaneous reservoir 
that confers continuous infusion of a therapeutic gene (Imaoka et al., 1998; Jackson et al., 
2001). As far as spinal cord gene delivery is concerned, lumbar intrathecal injection to 
the CSF is a less invasive route which makes multiple administrations feasible. Lumbar 
puncture due to the relatively wide subarachnoid space at the site and a decent measure of 
mobility of nerves within the CSF hence imposes little damage to the spinal cord. This 
route of delivery results in relatively prevalent transgene expression in the CNS and is 
ideal in treating degenerative neurological and neurogenetic disorders, spinal cord 
trauma, pain as well as fatal leptomeningeal metastases (Imaoka et al., 1998; Ram et al., 
1994; Meuli-Simmen et al., 1999; Martino et al., 2001). 
In the current study, repeat intrathecal administration of PEI-mediated gene 
delivery caused some inhibitory effects upon the second dosing. Potential mechanism for 
this inhibitory effect was investigated. Meanwhile PEG grafting, due to the advantages 
discussed above, eliminated the inhibitory effects in the repeat administration. It has been 
shown in the current study that PEG grafting is very promising in achieving successful 
repetitive administration for non-viral gene delivery.     
 
1.5 Conjugation of PEG to PEI and its Effect on Gene Expression Levels              
 
In the gene delivery system using non-viral vectors, PEI was shown to be a very efficient 
carrier capable of condensing and delivering DNA in vitro and in vivo (Boussif et al., 
1995; Abdallah et al., 1996; Goula et al., 1998). However, these are still
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many problems to be tackled with such as the transfection efficacy, aggregation and half-
life in the bloodstream, biocompatibility with less cytotoxicty and solubility problems 
(Nguyen et al., 2000) owing to charge neutralization. It is observed in the current studies 
that PEI/DNA complexes immediately precipitate out of a solution when prepared at a 
higher concentration. On the other hand, many in vivo studies are subject to the limited 
volume of a solution, indicating that a highly concentrated solution is necessitated for a 
high dose of DNA delivery and a significant gene expression. For instance, each rat 
intrastriatal injection usually uses 1 to 5µl of solutions. It was reported that  after direct 
brain injection PEI DNA complexes can provide transgene expression levels higher than 
those obtained with the HIV-derived vector and within the same range as that achieved 
with adenorival vectors (Abdallah et al., 1996).  
To deal with this problem, some research groups proposed linking a nonionic 
water-soluble polymer such as PEG to the polycationic polymers to improve the 
solubility of macromolecules, reduce aggregation of particulates and minimize their 
interaction with proteins in the physiological fluid (Ogris et al., 1999; Nguyen et al., 
2000; Choi et al., 2001; Kichler et al., 2002; Petersen et al., 2002a, b). It has been shown 
in some of their studies that PEGylation of PEI reduced zeta potential of PEI/DNA 
particles, improved their dispersion capacity at high concentrations, minimized plasma 
protein binding and erythrocyte aggregation, extended blood circulation time and 
improved biocompatibility after intravenous injection (Ogris et al., 1999; Nguyen et al., 
2000; Choi et al., 2001; Kichler et al., 2002; Petersen et al., 2002a, b). Effects of PEG 
grafting degree upon several cell lines have also been studied (Ogris et al., 1999; Nguyen 
et al., 2000; Choi et al., 2001; Kichler et al., 2002; Petersen et al., 2002a, b).  
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Interestingly, low degrees of PEGylation and high polymer nitrogen/DNA phosphate 
(N/P) ratio could greatly improve transfection expression in vitro (Petersen et al., 2002a). 
However, to the best of my knowledge, there has been no in vivo data available 
suggesting that the degree of the PEGylation would affect the efficacy of gene delivery. 
In the previous study, it has been shown that PEGylation could attain pronged transgene 
expression via repeated intrathecal administration. Then the optimization of PEGylation 
degree, if any would have provided further clues for repeated dosing. In this current 
study, it showed that a lower degree of PEGylation to PEI improved transgene expression 
in the CNS than those of higher degrees. 
 
1.6      Objectives of Present Studies 
 
Recently, there have been growing research interests in PEI-mediated gene delivery. 
However, possibility of PEI-mediated gene transfer in the rat central nervous system 
remains unexplored. Meanwhile, among other means of injection in the central nervous 
system, intrathecal administration has proved non-invasive and can achieve wide-spread 
transgene expression which is clinically important for many neuro-disorders. This study, 
combining the intrathecal route with PEI mediated gene transfer, may lead to 
establishment of new non-viral gene delivery in the central nervous system. On the other 
hand, due to some potential toxicity inherent in this polymer found in this study, various 
amounts of PEG have been conjugated to PEI and optimal conditions have been figured 
out. Anyway, this strategy not only makes it possible to achieve repetitive injection for 
long-term transgene expression which was considered as a big challenge for non-viral 
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gene transfer but also hints that it would be possible to make polycation biocompatible by 



























Branched PEI (25kDa) and PEG (2kDa) were obtained from Sigma-Aldrich (St. Louis, 
MO, USA).  PEI was purified through dialysis in three changes of a 100-fold volume 
excess of water, lyophilized, and re-hydrated before use. NHS-PEG-MAL (2kDa) was 
from Shearwater Polymers (Huntsville, AL). pGL-3-luc basic vector was from Promega. 
Immuno-staining kit, Qiagen kit, Luciferase kit, and TUNEL kit were obtained from 
Dako, Qiagen, Promega, and Roche, respectively. (3-(4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) was obtained from Sigma. Cell culture media were 
from Life Technologies.  
 
2.2 Synthesis of PEG-PEI 
 
One ml of PEI (0.1M) was mixed with various volumes of NHS-PEG-MAL solution 
(5mM). The mixture was stirred at room temperature for 45min, after which 50µL of 1M 
of glycine was added to quench the reaction. The compound was purified by PD-10 
column eluting with PBS solution (PBS containing 5mM EDTA), centrifugal filter and 
dialysis against water. The composition and molecular weight of PEG-PEI copolymers 
was determined from 1HNMR spectra using integral values obtained for the -CH2CH2O- 
protons of PEG and  CH2CH2NH- protons of PEI and from the MW values of the 
homopolymer PEI and PEG given by suppliers.  
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2.3 Plasmid  
 
 
The plasmid used was pCAGLuc (kindly donated by Yoshiharu Matsuura, National 
Institute of Infectious Diseases, Tokyo, Japan), encoding firefly luciferase driven by a 
composite promoter CAG consisting of the CMV IE enhancer, chicken β-actin promoter 
and rabbit β-globin polyadenylation signal. For plasmid pcDNA-lacZ, it was driven by 
CMV promoter. All plasmids DNA were amplified in E. coli and purified according to 
the suppliers protocol (Qiagen, Hilden, Germany). The quantity and quality of the 
purified plasmid DNA were assessed by optical density at 260 and 280nm and by 
electrophoresis in 1% agarose gel. The purified plasmid DNA was re-suspended in TE 
buffer and kept in aliquots at a concentration of 1mg/mL. To construct the non-coding 
plasmid pLuc-s, the Sal I/ Hind III luciferase fragment of pGL-3 basic vector (Promega, 
Madison, WI) was excised and replaced by Sal I/Hind III CAGLuc cassette from 
pCAGLuc. pLuc-s did not show any luciferase expression after in vitro cell transfection 
and in vivo intrathecal injection. 
 
 
2.4 Preparation and Characterization of DNA/Polymer Complexes  
 
 
The PEI or PEG-PEI/DNA complexes were prepared according to Boussif et al (1995). 
Plasmid DNA was diluted in 5% glucose to the chosen concentration (usually 0.5-
2µg/ul). After vortexing, the appropriate amount of 0.1M PEI or PEG-PEI was added 
drop-wise into DNA solutions and the solutions re-vortexed. The required amount of PEI, 
according to DNA concentration and number of equivalents needed, was calculated by 
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taking into account that lµg DNA contains 3nmol of phosphate and that lµl of 0.1M PEI 
holds 100nmol of amine nitrogen. PEI cation/DNA anion ratios were presented as the 
molar ratio of PEI nitrogen to DNA phosphate (N/P ratio).  
For agarose gel electrophoresis, polymer DNA complexes mixed with a loading 
buffer were loaded onto an ethidium bromide containing 1% agarose gel. Gel 
electrophoresis was run at room temperature in TEB buffer at 80V for 60min. DNA 
bands were visualized by a UV (254nm) illuminator.  
For complex size measurements, a N4 Plus Submicron Particle Sizer (Coulter, 
USA) was used. Scattering light was detected at 90° angles, running of 200sec at room 
temperature. For data analysis, the refractive index medium (1.332) of 5% glucose was 
used. The data obtained was analyzed in the unimodal analysis mode. 
For ethidium bromide intercalation assay, ethidium bromide (153µl of a 0.01% 
solution) was mixed with 96µg of pREluc and diluted to a final volume of 6ml. 50µl of 
the DNA-ethidium bromide solution was added into each well of a 96-well-microplate, 
followed by adding various concentrations of PEI (25kDa), PEG-PEI (1.3), PEG-PEI 
(2.5) and PEG-PEI (14.5) to obtain a final volume of 100µl per well. After mixing for 
5min, 100µl of distilled-water was added to each well. The fluorescene intensity was 
measured at 485nm excitation and 593nm emission using SPECTRAFluor Plus 
(TECAN).  
For a filtration assay to determine the interaction of polymer DNA complexes 
with serum, 12.8µg DNA in 20µl H2O were mixed with PEI or PEG-PEIs in 20µl H2O at 
N/P ratio of 6.0. After 30min incubation,  6µl fetal calf serum in 140µl H2O were added 
and incubated at 37°C for another 30min. 6µl fetal calf serum in 180µl treated in the 
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same condition was used as control. The membranes of Nanosep MF Centrifugal Devices 
(PALL Life Sciences, USA; 0.2µm) were blocked with 500µl bovine serum albumin 
(1mg/ml) to reduce non-specific binding of serum protein to the membrane and then 
washed 3 times with PBS. The mixtures of complexes and serum were filtered by 
centrifugation at 2000g for 1min and filtrates were collected. The membranes were 
washed 3 times with 500µl PBS, the serum protein bound to the complexes were eluted 
with 40µl 5% SDS in PBS. Both filtrates and elutes were loaded and separated on 4-20% 
Tris-HCl gradient gel. SilverXpress Silver Staining Kit from Invitrogen was used for 
staining. 
 
2.5 In Vitro Gene Transfer 
 
 
For the transfection of NT2 cells, the cells were split one day prior to transfection and 
plated in 24-well plates at a cell density of 5 × 10 4 per well with 0.5ml indicated medium.  
After overnight incubation, the culture medium was replaced with 300µl indicated 
medium and an aliquot of 10µl of polymer DNA complexes containing 0.1pmole DNA 
was added to each well of the plates. DNA complexes were incubated with the cells for 
24h at 37°C. After removing the incubation medium, cells were washed with PBS and 
permeabilized with 100µl of cell lysis buffer (Promega). The luciferase activity in cell 
extracts was measured using a luciferase assay kit (Promega). Measurements were made 
in a single-well luminometer (Berthold Lumat LB 9507, Germany) for 10sec. The RLU 
were normalized against protein concentration in the cell extracts, which was measured 
using a protein assay kit (Bio-Rad labs, Hercules, Calif). 
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2.6 Animals and Injection Procedures 
 
Adult male Wistar rats (8 weeks of age, 180-200g) were used throughout the study. 
Before each injection, the animals were anesthetized by intraperitoneal injection of 
sodium pentobarbital (60mg/kg). The lumbar injection was done using a 10µl micro-
syringe connected with a 26-gauge needle, after the skin around L4-L5 was exposed. The 
slight movement of the tail indicated the proper injection into the subarachnoid space. For 
each rat, 20µl of 5% glucose solution containing 4µg of plasmid DNA complexed with 
PEI or PEG-PEI were given by two injections. After a slow injection of 10µl of polymer 
DNA complexes over 2-5min, the syringe was left in place for 5min to limit diffusion of 
the DNA from the injection site owing to the backflow pressure. The skin was closed 
with surgical clips after the injection. The animals were kept warm until recovered.  
 
2.7 Luciferase Activity Assay 
 
Animals were intraperitoneally anesthetized with sodium pentobarbital and then perfused 
transcardially with 0.1M PBS (200ml/rat). After the perfusion, the whole spinal cord was 
exposed. The spinal cord was separated into cervical, thoracic and lumbar/sacral parts 
before homogenization. For some experiments, meninges were separated from the 
corresponding parts of the spinal cord. The tissue samples were homogenized with 400µl 
of lysis buffer (Promega), and then subject to three freeze-thaw cycles. The lysate was 
centrifuged at 14,000g for 5min at 40C, and 100µl of supernatant was used for the 
luciferase activity assay at room temperature  employing an assay kit from Promega. 
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Measurements were made in a single-well luminometer (Berthold Lumat LB 9507, 
Germany) for 10sec. 
 
2.8 Cell Viability Assay       
 
 
NT2 cells were cultured in DMEM supplemented with 10% FCS at 370C, 10% CO2 , and 
95% relative humidity. PC12 cells were cultured in rat tail collagen coated dishes in 
RPMI 1640 medium supplemented with 5% FCS and 10% heat-inactivated horse serum. 
For cell viability assay, the cells (10,000cells/well) were seeded into 96-well microtiter 
plates (Nunc, Wiesbaden, Germany). After 24h, culture media were replaced with serum 
supplemented tissue culture media containing serial dilutions of polymer or 
polymer/DNA complexes solutions and the cells were incubated for 24h. In some 
experiments, the cells were treated for 3h before changing back to normal culture media 
and the cell viability assay was done 21h later. For cell viability assay, 20µl sterile 
filtered MTT (3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (5mg/ml) 
stock solution in PBS was added to each well reaching a final concentration of 0.5mg 
MTT/ml. After 4h, un-reacted dye was removed by aspiration. The formazan crystals 
were dissolved in 100µl/well DMSO (BDH Laboratory Supplies, England) and measured 
spectrophotometrically in an ELISA plate reader (Model 550, Bio-Rad) at a wavelength 
of 655nm. The spectrophotometer was calibrated to 0 absorbance using culture medium 
without cells. Quintuplicate determinations for each treatment were performed. The 
relative cell growth (%) related to control cells cultured in media without polymer or 
polymer/DNA complexes was calculated by [A] test/ [A] control×100. 
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2.9 Histological Examination and Immunostaining  
 
 
Two or Three or fourteen days after PEI/DNA intrathecal injection, animals were 
anesthetized with sodium pentobarbital and perfused transcardially with saline solution 
(200ml) followed by 150ml of ice-cold fixative (4% paraformaldehyde, 0.05% 
glutaraldehyde in PBS). Tissues in lumbar and thoracic portions were removed 
respectively from the whole spinal cord and kept at 800C until sectioning. For H&E 
staining, paraffin-embedded sections were prepared. For immunostaining, the tissues 
were cut in short length and fixed on the plate with tissue freezing medium. After setting 
up on an ultramicrotome at 200C (OT) and 150C (CT) respectively, sections at 
thickness of 35µm were cut. The sections were transferred to gelatin-coated slide and 
fixed with acetone. A goat anti-luciferase (1/200, in PBS 1% BSA, Dako) and FITC 
conjugated anti-goat polyclonal antibody were used as the primary and secondary 
antibodies, respectively. After antibody incubation and washing, the sections were 
mounted in FluorSave (Calbiochem). Photographs were taken with digital camera 
attached to the microscope.  
 
2.10   TUNEL staining 
 
 
For in vitro TUNEL staining, NT2 cells were seeded in a 24-well plate with glass slides 
in each well, grown and treated as above. The slides were then fixed with a freshly 
prepared paraformaldehyde solution (4% in PBS, pH7.4). After 1h of fixation at RT, the 
slides were rinsed with PBS and incubated with blocking solution (3% H2O2) for 10min 
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at RT. The slides were then incubated in a permeabilization solution containing 
0.1%Triton® X-100 in 0.1% sodium citrate for 2min at 40C. After rinsing slides twice 
with PBS, 50µl of TUNEL reaction solution from the TUNEL staining kit (Roche) was 
added to each sample. After 60min incubation at 370C and washing, samples were 
analyzed under a fluorescence microscope. For the negative control, samples were 
incubated in 50µl of a label solution without terminal transferase. The same procedure 
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3.1 Repeated Administration 
 
3.1.1  Transgene Expression in the Spinal Cord After Intrathecal Delivery of 
PEI/DNA Complexes 
 
First, transgene expression with intrathecal delivery of naked DNA was investigated.   
Different amounts of naked plasmid pCAGLuc, ranging from 0 to 40µg, induced dose-
dependent transgene expression in the spinal cord. The peak of gene expression was seen 
when 20µg of DNA was used (Fig.1a). When plasmid DNA/PEI complexes were 
administrated, a significant increment in the transgene expression was observed. For 
instance, DNA/PEI complexes containing 4µg of DNA (at charge ratio of 15) yielded 
transgene expression 40-fold higher than equal amount of naked DNA. When comparing 
maximum levels, gene expression induced by PEI/DNA complexes (4µg of DNA at N/P 
ratio of 15) could be near 5-fold of that induced by 20µg of naked DNA (Fig. 1b). The 
efficiency of PEI-mediated transgene expression after intrathecal delivery was also ratio-
related. The maximum level was detected at a charge ratio of 15 equivalents of PEI 
nitrogen per DNA phosphate, with a luciferase activity of 2.5 x 105 RLU/spinal cord at 4 
µg of DNA (Fig.1c). The luciferase activity decreased when the charge ratio increased up 
to 20 equivalents. When distribution of gene expression was examined, peak levels were 
found in the thoracic, lumbar and sacral regions that are close to the injection site, with 
little expression in the cervical part and brain stem (Fig. 3a). In terms of time course for 
the PEI-mediated gene expression, significant level of luciferase activity in the spinal 
cord was observed as early as 1 day after intrathecal delivery (Fig. 1d). This level of gene 
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expression persisted for around 5 days. After that, it rapidly decreased in a magnitude of 
one order at day 7. However, the lower level of transgene expression could last even after 
8 weeks (Fig. 1d). 
To histologically determine the regions and cell types in the spinal cord that 
expressed luciferase or β-gal, cryostat sections of the lumbar and thoracic parts of the 
spinal cord were stained using antibodies against luciferase or β-gal. These pictures, 
among others, revealed a strong staining in meninges in animals receiving PEI/DNA 
complexes (Figs. 2A, 3B). The luciferase activity in this region accounted for 50% of the 
total activity in the whole spinal cord (Fig. 4b). Many positively stained cells were 
observed also in spinal parenchyma, with typical morphologies of astroglial 
cells,endothelial cells and neurons, respectively (Figs. 2, 3).  
 
3.1.2  Repetitive Injection: Attenuation of Gene Expression Upon Re-
administration 
 
To evaluate the feasibility of long-term gene expression facilitated by repeated injection 
of PEI/DNA complexes, a second injection was given at different time interval after first 
administration and the luciferase activities were assayed after 2 days. The control group 
was injected firstly with 5% glucose, a solution that was used to prepare PEI/DNA 
complexes, followed by the same procedure carried out to their counterparts. From the 
Fig. 5, it was observed that a repetitive injection of PEI/DNA two weeks after the first 
injection yielded a transgene expression that was 70% below control value. Nevertheless, 
as the time interval between the two injections increased up to 4 weeks, no reduction of 
gene expression was observed.  
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To figure out the underlying cause for the attenuation, each component of the 
PEI/DNA complexes was tested. First, naked DNA, up to a dose of 20µg, or PEI polymer 
alone, the same dose as PEI present in the complexes, did not cause any attenuation of 
transgene expression upon second injection of PEI/DNA complexes after two weeks (Fig. 
6). Then, complexes containing a non-encoding plasmid that did not mediate any gene 
expression did induce the reduction of gene expression (Fig. 6). Moreover, as the N/P 
increased from 15 to 50, the extent of attenuation worsened. These results suggested that 
PEI/DNA complexes were the major cause for the inhibitory effects observed in the 
repeated injection, not the components alone or transgene expression upon the second 
dosing. 
Knowing that the cytoxicity was inherent in the PEI polymer (Godbey et al., 
2001), the histology of the spinal cord intrathecally transfected by PEI/DNA complexes 
after two weeks was tested. H&E staining showed no histo-pathological and 
inflammatory effects (Fig. 7A&B). However, in the TUNEL staining from the same 
animal, bright nuclei in some cells were detected, indicating the nuclei fragmentation and 
apoptotic cell death. TUNEL positive cells mainly accumulated on the meninges of the 
thoracic and lumbar spinal cord (Fig. 7D). Some cells in the white mater were found to be 




                                       Chapter Three       Shi Lei 27 
3.1.3 PEI PEGylation Eliminates Attenuation of Gene Expression in Repetitive 
Administration 
 
Some studies have revealed that PEI PEGylation may reduce its cytotoxicity (Ogris et al., 
1999; Nguyen et al., 2000; Kichler et al., 2002). PEI was covalently modified with PEG. 
The ratio of PEG vs. PEI was 2.5, as determined from 1H-NMR spectra using integral 
values obtained for the CH2CH2O- protons of PEG and CH2CH2NH- protons of PEI. 
PEGylation of PEI at this ratio did not significantly affect the amount of polymer 
required to retard the DNA (Fig. 8). The influence of PEGylation on size of DNA 
polymer complexes was also studied through light scattering (Table 1). Complexes were 
prepared the same way as used in the current in vivo experiments. Two peaks were 
detected in the size measurement of PEI/DNA complexes at N/P ratio of 15. The 
dominant one that occupied 44% of complexes, revealed an average diameter of 136nm 
and another (28%) was 754nm. The second portion was probably some aggregation of the 
complexes. When it comes to PEGylated PEI, a small complex of 93nm was observed. 
This result is consistent with a recent finding, 6 demonstrating that conjugation of one or 
two PEG to PEI could enhance DNA condensation forming compact complexes smaller 
than those obtained by PEI alone. Besides, the percentage of the second portion of PEG-
PEI complexes with a much larger diameter (826nm) decreased compared to PEI 
complexes, accounting for only 7%. 
Another advantage of PEGylated PEI was shown in the cytotoxicity assay 
conducted in two neuronal precursor cell lines, PC12 and NT2/D1 cells (Fig. 9). In 
addition to less toxicity, PEG-PEI also promoted cell proliferation in both cell lines at 
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lower concentrations (Fig. 9). In another experiment, cell toxicity was examined in 
NT2/D1 cells using DNA/polymer complexes rather than polymer alone to more closely 
mimic the in vivo profile of these polymers. DNA/polymer complexes were more toxic 
than polymers alone (Fig. 10). PEGylation also contributed to less PEI cell toxicity when 
used with DNA as the complexes (Fig. 10). Meanwhile, apoptosis reduced significantly 
in NT2/D1 cells after PEI PEGylation, as shown in the TUNEL staining. For instance, 
0.5µM PEI provoked typical apoptotic nuclear morphology, with chromatin 
fragmentation into bright patches (Fig. 7f). Under the same concentration of PEG-PEI, no 
cells were stained for TUNEL (Fig. 7e). 
PEG-PEI mediated transgene expression in the intrathecal delivery model was 
further investigated. Gene expression in the spinal cord mediated by PEG-PEI showed 
dose-dependent tendency, reaching the plateau at 4µg DNA (Fig. 11A). The efficacy in 
PEG-PEI mediated transgene expression increased when the charge ratios were raised, 
with the peak luciferase activity of 4.848 x 105 RLU/ spinal cord at N/P ratio 40 (Fig. 
11B). The distribution of transgene expression, however, had not changed for PEG-PEI 
mediated delivery (data not shown). Besides, time course study of PEG-PEI was carried 
out and at three or five days transgene expression reached the peak, almost five-fold 
higher than the one attained by PEI-mediated transfection (data not shown).  Then the 
repeated administration with PEG-PEI was also conducted. A second injection of 
polymer DNA complexes was given after 2 weeks of the first injection of PEG-PEI/DNA 
complexes or 5% glucose solution and luciferase activities were measured 48h later. No 
reduction of gene expression levels between animals receiving PEG-PEI/DNA complexes 
and control animals (Fig. 12) was observed. In another experiment, each animal receiving 
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three injections, administrated 2 weeks apart. There was also no evidence of inhibitory 
effects of previous injections upon the next one (Fig. 12). 
 
3.2 Effects of PEGylation Extent upon CNS Gene Transfer 
 
 
3.2.1 Synthesis and Physicochemical Characterization of PEG-PEI 
 
    
A couple of cationic copolymers were synthesized by the above method and 25kDa PEI 
and 2kDa PEG were used in all reactions. Characterization with H-NMR revealed that 1, 
1.3, 2.5, 5 and 14.5 blocks of PEG was conjugated to each of PEI macromolecules 
respectively (Fig. 13). 
 To examine the effect of PEGylation upon condensation capacity of modified 
PEI, gel retardation assay was done. At various N/P ratios, DNA polymer complexes 
were prepared in 5% glucose. After being incubated for 30min, these solutions were 
loaded for agarose electrophoresis. As shown in Fig. 14, at N/P ratio of 3 DNA was 
retarded by PEI, PEI conjugates with 1 or 2.5 blocks of PEG. However, when it comes to 
PEI conjugated with 14.5 blocks of PEG, complete neutralization of DNA required a 
higher N/P ratio of 7. In addition, DNA neutralization and condensation by PEG-PEI was 
further examined by inhibition of ethidium bromide (EB)/DNA fluorescene. This assay 
was consistent with gel retardation assay (data not shown). 
 To study the effect of PEGlyation on the interaction of polymer DNA complexes 
with proteins, complexes were incubated with serum. Proteins bound were recovered by 
dissolving in SDS and visualized in SDS-PAGE gel after electrophoresis and staining. As 
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shown in Fig. 15, a reduction in binding of serum proteins was observed in DNA 
complexes of PEGylated PEI copolymers, even in the complexes of PEI conjugate with 
only 1.3 blocks of PEG.      
            Considering that the particle size could affect transfection efficacy, the sizes of 
these complexes by light scattering were also measured. It revealed that PEG-PEI/DNA 
complexes were relatively uniform and most of them were smaller than PEI/DNA 
complexes (Table 2), a size of benefit to gene delivery. 
 
3.2.2 Protection Effects for PEGylated PEI 
          
It is shown in many studies that PEGylation could enhance biocompatibility. To know the 
effects of PEGylation extent on the cytotoxicity of PEI, MTT assay was conducted in one 
neuronal precursor cell line NT2/D1 (NT2) (Fig. 16). It showed that lower degree of 
PEGylation, like 1 block PEG per PEI, could not significantly enhance cell viability at all 
concentrations tested. However, higher degree of PEGylation, like 5 blocks of PEG or 
more per PEI, was very potent in improving cell viability even at the highest 
concentration of 2mN of polymers. For the moderately PEGylated PEI, like 2.5 blocks of 
PEG per PEI, it protected cell from PEI cytoxicity at lower concentrations but had no 
effects of protection when the concentration of polymer increased up to 2mM. 
 
3.2.3 PEI PEGylation Enhanced Gene Delivery In Vitro 
 
 
To examine the PEGylation effects upon in vitro gene delivery, transfection experiments 
in NT2 cell lines was carried out in the presence and absence of serum (Fig. 17). Without 
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serum, in contrast to PEI DNA complexes PEG-PEI (1) complexed with DNA showed 
around 10 fold improvement in transgene expression while PEG-PEI (5) revealed a much 
lower level of gene expression than PEI and PEG-PEI (1). With serum, although all these 
polymers revealed reduced efficiency in gene expression, less reduction was shown for 
PEG-PEI polymers. The gene expression attained by PEI in a serum-containing medium 
was only 6% of that in a serum free medium. For PEG-PEI (1) and PEG-PEI (5), the 
expression levels in the serum-containing medium were 29% and 38 % of the 
corresponding levels without serum respectively, suggesting that PEGylation can reduce 
the protein inhibitory interaction with PEI DNA mediated transgene expression. 
            To figure out the effects of charge ratios upon transfection efficacy, NT2 cells 
were tranfected by DNA complexed by PEI with various modification extents of PEG in 
a serum-containing medium for 24h till analysis of luciferase activity (Fig. 18). In 
contrast to unmodified PEI, PEG-PEI (1) and PEG-PEI (1.3) enhanced gene delivery. 
However, when PEGylation degree increased up to 2.5 blocks of PEG per PEI, transgene 
expression began to decrease. Further reduction was seen in copolymer with PEG/PEI 
ratios of 5 and 14.5. Compared to its transfection level at a lower N/P ratio, PEG-PEI 
(14.5) was relatively more efficient in transgene expression at higher N/P ratios between 
40 to 70 (Fig. 19). 
 
3.2.4 PEG-PEI Mediated In Vivo Gene Delivery 
 
To determine histologically the regions and cell types in the spinal cord that expressed 
luciferase, cryostat sections of the lumbar and thoracic parts of the spinal cord were 
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stained using antibodies against luciferase. A strong staining was seen in spinal meninges 
in animals receiving PEG-PEI (1)/DNA complexes (Fig. 20D). Many positively stained 
cells were observed also in spinal Parenchyma (Fig. 20).  
            As shown in Fig. 10A, the effect of PEGylation extent to PEI-mediated transgene 
delivery in the CNS was first studied at N/P ratio of 20. PEG-PEI (1) mediated transgene 
expression was almost 3 fold of that achieved by PEI. For PEG-PEI (2.5), it had also 2-
fold increment while high PEGylation degree PEG-PEI (14.5) did not show any 
improvement. Then at various N/P ratios ranging from 10 to 40, PEG-PEI (1) yielded 
transgene expression higher than PEI alone (Fig. 21B). The increment ranged from 3 to 
10 fold depending on N/P ratios. 
            In a time course study of PEG-PEI (1)/DNA and PEI/DNA complexes, the 
intrathecal injection yielded maximum level of luciferase activity in the spinal cord as 
early as 1 day after injection (Fig. 21C). After that it rapidly declined, with a low level of 
expression detectable after 28 days. At three time points, PEG-PEI (1) mediated 
transgene expression was higher than that attained by PEI. 
            To compare the distribution difference in transgene expression by PEG-PEI (1) 
and PEI, tissues from various parts of the CNS were taken for luciferase activity (Fig. 
22). Fig.10A revealed that PEG-PEI (1) mediated transgene expression in lumbar thoracic 
and cervical spinal cord was all significantly higher than that attained by PEI. 
Considerable amount (around 50%) of PEG-PEI (1) mediated transgene expression was 
detected in parenchyma of spinal cord, while the rest accumulated in spinal cord 
meninges (Fig. 22B). The similar distribution was observed after intrathecal injection of 
PEI/DNA complexes, but again the luciferase activity in all parts was lower than that 
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mediated by PEG-PEI (1) (Fig. 22B). For the luciferase activity in brainstem, cerebellum, 
cerebral cortex and basal nuclei/diencephalons, PEG-PEI (1) had an easily detectable 
level while PEI only had readings close to background (Fig. 22C). The results indicate 
that PEG-PEI could mediate transgene expression more efficiently in terms of both levels 
and distance than PEI. This feature facilitates the need for widespread transgene 
expression. 
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Fig.  1 (a) Luciferase activities in the spinal cord. Dose response of plasmid DNA 
pCAG-Luc 2 days after lumbar intrathecal injection. 
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Fig. 1 (b) Luciferase activities in the spinal cord.  Dose response of plasmid DNA 
pCAG-Luc complexed with PEI 2 days after lumbar intrathecal injection. The N/P 
ratio used was fixed at 15. 
















































Fig. 1 (c) Luciferase activities mediated by PEI DNA complexes in the spinal 
cord. Effects of N/P ratios 2 days after injection. Four µg of DNA was used for each 
rat.  













































Fig.1 (d) Luciferase activities in the spinal cord. Time course of luciferase
activities in the spinal cord. Four µg of DNA at N/P ratio of 15 was used for each rat. 
Five to ten rats were used per group. Values are presented as means ± SEM.  
 





























   
 
Fig.2  Localization of luciferase expression in the spinal cord.
Immunostaining with an antibody against luciferase 2 days after lumbar intrathecal
injection of PEI pCAG-Luc complexes at N/P=15. A strong staining in meninges is 
shown in (A). Positively stained cells in the spinal parenchyma exhibit different
morphologies. Possible cells in (B), (C) and (D) are astrocytes, neurons and microglia,
respectively.  
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Fig. 3.           Localization of β-gal expression in the spinal cord. Immunostaining with
an antibody against β-gal 2 days after lumbar intrathecal injection of PEI pcDNA-lacZ 
complexes at N/P=15. A strong staining in meninges is shown in (B). Positively
stained cells in the spinal parenchyma exhibit different morphologies. Possible cells in
(A), (C) and (D) are astrocytes, endothelial cells and neurons, respectively. 
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Fig. 4 (a) Distribution of luciferase activity in various parts of the spinal cord. 
Luciferase activities in the lumber/sacral, thoracic, and cervical segments of the spinal
cord, as well as the brain stem. Four µg of DNA at PEI/DNA ratio of 15 was used for 
each rat. Five rats were used per group. 
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Fig. 4 (b) Distribution of luciferase activity in various parts of the spinal cord.
Comparison of luciferase activities in meninges and parenchyma of the lumbar/sacral 
and thoracic spinal cord. Four µg of DNA at PEI/DNA ratio of 15 was used for each
rat. Five rats were used per group. 
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Fig. 5 (a) Repetitive administration of PEI/DNA complexes at different time
intervals. Four µg of DNA was complexed with PEI at N/P=15 and injected 
intrathecally. The control rats received an injection of 5% glucose vehicle. After 1, 2,
4 and 8 weeks, all rats were given a second injection of 4µg of DNA complexed with 
PEI at N/P=15. Rats were sacrificed 48h later. Five to fifteen rats per group were used. 
Values are presented as RLU per tissue. For group at 2 weeks time point, P<0.0005. 
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Fig. 5 (b) Repetitive administration of PEI/DNA complexes at different time
intervals. Four µg of DNA was complexed with PEI at N/P=15 and injected 
intrathecally. The control rats received an injection of 5% glucose vehicle. After 1, 2,
4 and 8 weeks, all rats were given a second injection of 4µg of DNA complexed with 
PEI at N/P=15. Rats were sacrificed 48h later. Five to fifteen rats per group were used. 
Values are presented as RLU percentage of controls . 
























































































Fig. 6.  Identification of agents responsible for the inhibitory effects in the
repetitive injection. The first injection used 5% glucose vehicle, PEI polymer alone,
naked DNA (20µg), or non-coding plasmid DNA (pLuc-s, 4µg) complexed with PEI 
at different N/P ratios of 15, 30, 50, respectively. After 2 weeks, all rats were given
a second injection of 4µg of DNA complexed with PEI at N/P=15. Rats were
sacrificed 48h later. Ten rats per group were used. 
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Fig. 7.   Micrographs of the spinal cord and NT2/D1 cells. a & b: H&E stained tissue
sections from a control animal (a) and an animal intrathecally injected with 4µg of DNA 
complexed with PEI at N/P=15 (b). The samples were collected 2 weeks after injection. c & d:
TUNEL stained tissue sections from a control animal (c) and an animal intrathecally injected
with 4µg of DNA complexed with PEI at N/P=15 (d). The arrow indicates TUNEL positive 
cells. The samples were collected 2 weeks after injection. Note TUNEL positive cells in
meninges in d. e & f: TUNEL stained NT2 cells after incubation with 0.5µM PEG-PEI (e) or 
0.5µM PEI (f) for 24h. The original photographs were taken at x 200 magnification. 
































Fig. 8.   Agarose gel electrophoresis of 0.5µg of pcDNAlacZ plasmid DNA and 
its complexes with 25kD PEI or PEG-PEI at N/P ratios from 0 to 4.   
 













































 Fig. 9 (a) Cell viability assay in NT2/D1 cells. The cells were treated with
various concentrations of PEI or PEG-PEI for 24h in a serum-containing medium. 
Cell viability was determined by a MTT assay and expressed as percentage of control,
i.e. the untreated sister cultures. Each point represents the mean + SEM of four 
cultures. The data shown here are representative of three independent experiments. 
 















































Fig. 9 (b) Cell viability assay in PC12 cells. The cells were treated with various
concentrations of PEI or PEG-PEI for 24h in a serum-containing medium. Cell 
viability was determined by a MTT assay and expressed as percentage of control, i.e.
the untreated sister cultures. Each point represents the mean + SEM of four cultures. 
The data shown here are representative of three independent experiments. 
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Fig. 10 (a)  Cell viability assay with DNA/polymer complexes in NT2/D1 cells.
The cells were treated with various concentrations of DNA/polymer complexes or 
polymers, expressed as amount of nitrogen or phosphate, for 3h in a serum-containing 
medium. Cell viability was determined by a MTT assay and expressed as percentage
of control, i.e. the untreated sister cultures. Each point represents the mean + SEM of 
























































































Fig. 10 (b) Cell viability assay with DNA/polymer complexes in NT2/D1 cells.
The cells were treated with various concentrations of DNA/polymer complexes or
polymers, expressed as amount of nitrogen or phosphate, for 24h in a serum-
containing medium. Cell viability was determined by a MTT assay and expressed as
percentage of control, i.e. the untreated sister cultures. Each point represents the mean
+ SEM of four cultures. For all doses, P<0.005. 
 

















































Fig.11 (a) Gene expression in the spinal cord mediated by PEG-PEI. Dose 
response of plasmid DNA pCAG-Luc complexed with PEG-PEI, 2 days after lumbar 
intrathecal injection. PEI/DNA ratio of 20 was used.  
 











































Fig.11 (b) Gene expression in the spinal cord mediated by PEG-PEI. Effects of 
PEI/DNA ratios, 2 days after injection. Four µg of DNA was injected into each rat. 
Eight rats per group were used. Values are presented as means ± SEM. 
 








































Fig. 12.  Repetitive injection with DNA/PEG-PEI complexes. In the experiment 
with 2 injections, rats were first given 5% glucose (vehicle control group) or 4µg of 
DNA complexed with PEG-PEI at N/P ratio 20 (PEG-PEI group) and then a second 
injection of 4µg of DNA complexes for all animals 2 weeks later. In the experiment 
with 3 injections, rats were given two doses of 5% glucose (vehicle control group) or 
4µg of DNA complexed with PEG-PEI (PEG-PEI group) followed by a third injection 
of 4µg of DNA complexes for all animals at biweekly intervals between the three 
administrations. Rats were sacrificed 48h after the last injection for luciferase activity
assay. Eight rats per group were used.  

























Fig. 13 (A) Proton NMR of PEG-PEI (1.3)with different modification degree. The 
ratios of PEG and PEI in the copolymers were determined from 1HNMR spectra using 
integral values obtained from the number of CH2CH2O- protons of PEG and 
CH2CH2NH- protons of PEI. The peaks at 3.6ppm were assigned to protons of PEG,
and the peaks at 2.5-3.2ppm to protons of PEI. 















































Fig. 13 (B)   Proton NMR of PEG-PEI (2.5) with different modification degree. The 
ratios of PEG and PEI in the copolymers were determined from 1HNMR spectra using 
integral values obtained from the number of CH2CH2O- protons of PEG and 
CH2CH2NH- protons of PEI. The peaks at 3.6ppm were assigned to protons of PEG,
and the peaks at 2.5-3.2ppm to protons of PEI. 
 

















































Fig. 13 (C) Proton NMR of PEG-PEI (14.5) with different modification degree. 
The ratios of PEG and PEI in the copolymers were determined from 1HNMR spectra 
using integral values obtained from the number of CH2CH2O- protons of PEG and 
CH2CH2NH- protons of PEI. The peaks at 3.6ppm were assigned to protons of PEG,
and the peaks at 2.5-3.2ppm to protons of PEI. 



















































          
PEI        0    1/1   1.3/1 1.6/1 2/1   3/1    4/1   5/1 
 
 
          
 
PEG-PEI(1.3)   0     1/1   1.3/1 1.6/1 2/1   3/1   4/1   5/1 
 
         
 
PEG-PEI(2.5)  0     2/1   2.6/1   3/1   4/1    5/1    6/1    7/1 
 
 
         
 
PEG-PEI(14.5) 0      2/1     3/1    4/1    5/1     6/1     7/1   
 
Fig. 14. Agarose gel electrophoresis of 1.0µg pRELuc DNA complexed with 
PEI, PEG-PEI (1.3), PEG-PEI (2.5) and PEG-PEI (14.5) at N/P ratio from 0 to 7. 
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Fig. 15. The interaction of polymer DNA complexes with proteins. Complexes 
were incubated with serum as described in Materials and Methods. Proteins bound
were recovered by dissolving in SDS and visualized in SDS-PAGE gel after 
electrophoresis and silver staining. Lane 1, 3, 5, 7, unbound proteins collected by
centrifugation as filtrates. Lane 2, 4, 6, 8, bound proteins eluted with SDS. Lane 1 and
2: PEI DNA complexes; Lane 3 and 4: PEG-PEI (1.3) DNA complexes; Lane 5 and 6: 
PEG-PEI (2.5) DNA complexes; Lane 7 and 8: PEG-PEI (14.5) DNA complexes. 










































































Fig. 16. Cytotoxicity of PEI and PEG-PEI copolymers in NT2 cell lines. The 
cells were treated with various concentrations of polymers for 24h in a serum-
containing medium. Cell viability was determined by a MTT assay and expressed as
percentage of control, i.e. the untreated sister cultures. Each point represents the
Mean±SEM (n=4). 

























































































Fig. 17. Effects of serum on gene delivery mediated by PEG-PEI. NT2 cells 
were treated with copolymer/DNA complexes in medium with or without serum for
24h in 24 well plates. 0.5µg pCAGluc plasimd was used per well. (A) Luciferase
activity of PEI and PEG-PEIs mediated gene delivery in serum-containing and serum-
free medium. (B) Percentage of the gene expression level in a serum-containing 
medium to that in a serum free medium. 









































































































Fig. 18  Effects of PEGylation extent on PEI-mediated gene delivery in NT2 
neuronal precursor cells in the presence of serum. NT2 cells were treated with DNA
complexed by PEI or PEG-PEI copolymers in serum containing medium for 24h in 24
well plates. 0.5µg pCAGluc plasimd was used per well. The N/P ratios used were 5,
10, 20 and 30, respectively.  
 






































































Fig. 19  Effects of N/P ratios on gene expression mediated a PEI conjugate with
14.5 segments of PEG in NT2 neuronal precursor cells in the presence of serum. NT2 
cells were treated with DNA complexed by the PEG-PEI copolymers in serum 
containing medium for 24h in 24 well plates. 0.5µg pCAGluc plasimd was used per 
well. 
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Fig. 20  Localization of luciferase expression in spinal cord. Immunostaining 
with an antibody against luciferase 3 days after post-injection. Each animal was 
injected with 4 microgram DNA complex by PEG-PEI(1) at N/P ratio 20. (A) and (B) 
Controls; (C) Positively stained cells in spinal cord parenchyma; (D) Spinal cord 
meninges. 
 







































































Fig. 21 (A) Luciferase activities in the spinal cord after intrathecal injection of
PEI/pCAGLuc and PEG-PEI/pCAGluc complexes. Effects of PEGylation extent 3
days after injection. N/P charge ratio at 20/1 was used for complexe preparation.  Five 
















































































Fig. 21 (B) Luciferase activities in the spinal cord after intrathecal injection of
PEI/pCAGLuc and PEG-PEI/pCAGluc complexes. Effects of N/P charge ratios 3 days 
after injection. Four microgram of DNA plasmid was used for each rat injection. Five
or ten rats per group were used. Values were presented as mean±SEM. 
 






































































Fig. 21 (C) Luciferase activities in the spinal cord after intrathecal injection of 
PEI/pCAGLuc and PEG-PEI/pCAGluc complexes. Time course study. Four
microgram of DNA plasmid was used for each rat injection. Five or ten rats per group
were used. Values were presented as mean±SEM. 
 






































































Fig. 22 (A) Distribution of luciferase expression in various parts of central nervous
system 2 days after injection. Four microgram of plasmid DNA was used for each rat
injection. N/P charge ratios were 15/1 for PEI DNA complexes and 20/1 for PEI-PEG 
(1) DNA complexes. Five to ten rats per group were used. Values were presented as
mean±SEM. 
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Fig. 22 (B) Distribution of luciferase expression in various parts of central nervous
system 2 days after injection. Four microgram of plasmid DNA was used for each rat
injection. N/P charge ratios were 15/1 for PEI DNA complexes and 20/1 for PEI-PEG 
(1) DNA complexes. Five to ten rats per group were used. Values were presented as
mean±SEM. 
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Fig. 22(C) Distribution of luciferase expression in various parts of central nervous
system 2 days after injection. Four microgram of plasmid DNA was used for each rat
injection. N/P charge ratios were 15/1 for PEI DNA complexes and 20/1 for PEI-PEG 
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  Particles                                              Aggregates                                    
Mean (nm) SD (nm) % Mean (nm) SD (nm) % 
 
PEI   136  25  44      754  112  28 
(n=7) 
    








* Complexes were prepared at a DNA concentration of 0.2mg/ml, N/P ratio = 15 for 
PEI and N/P = 20 for PEG-PEI complexes. A volume of 1ml was used for the
measurement. Sizes were measured with N4 Plus Submicron Particles Sizer (Coulter,
USA) at room temperature. Scattering light was detected at 900 angle, running for 
200sec for each sample, and analyzed in the unimodal analysis mode. For data
analysis, the refractive index medium (1.332) of 5% glucose at room temperature was
used.  
 









Table 2: Size distribution of polymer DNA complexes 
 
Percentage                                            Size (nm)                                     
                             
Copolymer                      <200                             200-700            >1000 
 
PEI              37.8%                           36.5%                              7.5% 
PEG-PEI (1)       75.1%                             6.0%                              0.0% 






Complexes were prepared at a DNA concentration of 0.1mg/ml, N/P ratio = 10 for 
PEI, PEG-PEI (1), and PEG-PEI (14.5). A volume of 1ml was used for the
measurement. Sizes were measured with N4 Plus Submicron Particle Sizer (Coulter,
USA) at room temperature. Scattering light was detected at 90° angle, running of 200 
sec for each sample and analyzed in the unimodal analysis mode. For data analysis,
the refractive index medium (1.332) of 5% glucose at 20°C was detected. 
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Discussion and Conclusion 
 
The blood-brain barrier makes a vascular route formidable for transgene delivery to the 
CNS. Therefore, direct stereotactic injection into specific region rises as the most 
commonly used approach for gene delivery to the CNS. However, its invasive feature and 
localized transgene expression in the immediate vinicity of the injection site restrains the 
procedure from certain clinical applications. On the other hand, intraventricular or 
intrathecal administration into CSF may lessen direct damage to CNS tissue and makes it 
possible to attain widespread transgene expression in the whole organ. Lumbar puncture 
is a routine and relatively non-traumatic clinical practice, allowing a safe repeat 
administration of gene delivery. Owing to CSF flow, the distribution of transgene 
expression in the CNS after intrathecal injection is relatively limited. In the current study, 
the transfection was accumulated in the sacral, lumbar and thoracic regions, although 
lower but detectable transgene expression could be observed in the cervical regions and 
brain stem. Even PEG-grafted PEI could not change the distribution. The distribution of 
transgene expression induced by PEI in this study was consistent with the finding by 
Abdallah et al (1996) but different from the report using cationic liposome (Meuli-
Simmen et al., 1999) or adenoviral vectors (Mannes et al., 1998), which showed a 
restricted gene expression in meninges. 
The nature of transient expression for non-viral gene delivery system can be 
considered as one disadvantage, depending on applications. To tackle this problem, 
repeated dosing could be employed. In terms of cationic lipidic vectors, repeated 
intravenous administration does not prove effective at frequent intervals (Li et al., 1999; 
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Meyer et al., 2000; Tan et al., 1999). These studies suggested that lipoplex triggered 
apoptosis and production of pro-inflammatory cytokines including infereron-γ and tumor 
necrosis factor-α and unmethylated CpG sequences in plasmid DNA also accounted for 
the direct immunostimulatory effects. Anyway, these two main causes explained the 
ineffectiveness in the repeat injection (Li et al., 1999; Meyer et al., 2000; Tan et al., 
1999). The same mechanism may also apply to PEI-mediated gene delivery system and 
be accountable for detected apoptotic cell death in the spinal cord after intrathecal 
administration. The CNS is considered as an immune priviledged site and inflammatory 
and immune cells do not function in the CNS as efficiently as in other organs. However, 
CNS ventricles and parenchyma are immunologically separated. Delivery of antigens and 
viruses into CSF elicited immune responses, probably owing to antigenic presentation in 
the deep cervical lymph nodes (Fabry et al., 1994; Stevenson et al., 1997). Cell death and 
apoptosis could also be induced by over-expression of gene products (Detrait et al., 
2002), but this could not be used to explain what happened in this study, considering the 
observation that non-coding plasmid pLuc-s complexed with PEI prompted inhibitory 
effects too. The potential problem inherent in physiological conditions when these 
complexes were injected is much higher ionic strength that may speed up the aggregation 
of complexes and impair the transfection efficacy (Ogris et al., 1999; Goula et al., 1998). 
In addition, the larger aggregates showed acute toxicity after intravenous injection and 
may kill 50% of the animals within 30min further suggesting that PEI/DNA complexes, 
especially their aggregates or precipitates, may also be accountable for cell death. It is 
noteworthy that apoptosis was found exclusively in meninges. The pia mater of spinal 
meninges builds up the boundary of the CSF and 
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spinal parenchyma, playing as  one of the major barriers in transporting DNA/polymer 
complexes from the CSF to the spinal cord tissues. Consistent with a previous report 
using intracerebro-ventricular injection of PEI/DNA complexes (Abdallah et al., 1996), it 
has been also observed in the current study considerable transgene expression in CNS 
parenchyma after CSF gene delivery, indicating PEI/DNA complexes may penetrate 
through the pia mater. No apparent cell death in the gray and white maters of the spinal 
cord was observed, further indicating that PEI/DNA entering the spinal parenchyma may 
not be toxic to glial cells and neurons at these low doses. This is also consistent with the 
previous report that PEI/DNA complexes delivered through a retrograde axonal transport 
did not inflict toxicity upon brainstem neurons at concentration efficient for DNA 
transfection (Wang et al., 2001). However, part of the formed aggregates could attach on 
the surface of the pia/dura mater, leading to death of leptomeningeal cells. Further study 
is needed to identify the underlying mechanism of apoptosis observed in the current 
study. 
The apoptotic cell death detected in this study was correlated with reduction of 
transgene expression following a second administration. As demonstrated in this study, 
the attenuation is not due to PEI polymer itself because injection of the polymer alone did 
not induce any inhibitory effects. Neither is the attenuation caused by the gene expression 
because high dose of naked DNA had no effects and injection of the complexes 
containing non-encoding plasmid DNA was as inhibitory as those containing functional 
plasmid DNA. It shows that PEI/DNA complexes, rather than separate component alone, 
are the underlying cause for the attenuation. On the other hand, PEI polymer alone is 
probably capable of inducing apoptosis at higher concentrations, as revealed in the in 
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vitro experiment of this study. In an in vivo study using PEI alone into the CSF, such as 
the one reported here, opsonization of the highly positively charged polymer might 
reduce its cytotoxic effects. Indeed, PEI polymer alone was less toxic than PEI/DNA 
complexes in in vitro cell viability assay in the serum-containing medium (Fig. 10). 
Reduced toxicity may also be attributed to relatively inefficient cellular uptake of the 
branched 25kDa PEI compared to PEI/DNA complexes. Meanwhile, naked plasmid DNA 
alone is very volatile in the body fluid and may degrade quickly. DNA degradation may 
reduce CpG content (Abdallah et al., 1996; Li et al., 1999), thus minimizing CpG-
triggered immune response. 
PEG grafting to PEI in this study abolishes apoptosis and inhibitory effects in the 
repeat administration of DNA/polymer complexes. The precise underlying mechanism is 
largely unknown. One of the disadvantages for using polycations, including PEI, is poor 
solubility of DNA/polymer complexes, especially at higher N/P ratios. Precipitates or 
aggregates of these complexes could be more toxic than their non-aggregated 
counterparts and polymer alone, as suggested in the finding that the higher the N/P ratio, 
the stronger the inhibitory effects. PEG grafting often can provide improved solubility of 
macromolecules, reduce aggregation of particulates and minimize their interaction with 
proteins in the physiological fluid. There is evidence from previous studies that 
PEGylation of PEI reduced surface charge of PEI/DNA particles, increased their 
dispersion ability at high concentrations, minimized plasma protein binding and 
erythrocyte aggregation, prolonged blood circulation time and decreased systemic 
toxicity after intravenous administration (Ogris et al., 1999; Nguyen et al., 2000; Kichler 
et al., 2002). Some of these effects may have contributed to the improvements in gene 
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expression upon repeat dosing achieved in the present study. Indeed, previous reports that 
PEGylation of polycations leads to enhanced transfection efficiency (Petersen et al., 
2002b; Choi et al., 1998; Lee et al., 2001; Sagara et al., 2002; Ahn et al., 2002) was 
consistent with the current in vivo study which showed PEGylation improved transfection 
five fold higher than PEI (data not shown). 
PEG could modify proteins and peptides, rendering them less immunogenic and 
antigenic thanks to reduced immune presentation by PEG-conjugated steric hindrance 
(Francis et al., 1998; Harris et al., 2001; Hinds et al., 2002). Covalent attachment of PEG 
to the surface of the adenovirus (Chillon et al., 1998; ORiordan et al., 1999) reduces both 
humoral and cellular immune responses against viral proteins, attaining substantial gene 
expression of the vector upon second dosing without compromising the immune system 
of immunocompetent animals (Croyle et al., 2000). There is still a possibility that 
PEGylation of PEI in the present study might reduce immune stimulatory effects of CpG 
motifs in plasmid DNA once PEI/DNA complexes were formed, thus affecting cell 
susceptibility and gene expression profiles in the repetitive injection. However, some 
potential side effect is higher degree of PEGylation can undermine transfection efficiency 
(Nguyen et al., 2000; Petersen et al., 2002b), probably because of steric hindrance effects 
of PEG on the interactions of the complexes with the cells (Nguyen et al., 2000). A 
proper grafting degree may balance the stabilizing benefits and hindrance effects and 
thereby becomes critical in achieving efficient in vivo gene delivery.  
Out of this consideration, effects of PEG grafting extent on the in vivo gene 
delivery of PEI were investigated. Polymer DNA complexes were delivered into the 
lumbar subarachnoid space. A low degree of grafting, one PEG block per each PEI 
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polymer, was capable of enhancing transgene expression in the spinal cord and the brain. 
This result is consistent with a recent report (Petersen et al., 2002b) that showed 
improved in vitro gene expression mediated by PEI after conjugating only one or two 
PEG blocks per PEI. Improvement in transgene expression in the study did not indicate 
the well-documented effect of PEG in enhancing biocompatibility, since low degree of 
PEG grafting did not allow cell to survive in the high concentration of polycations. The 
effect of PEG in improving cell viability was only observed when the grafting degree 
increased up to 2.5 or more blocks of PEG in the study. However, as revealed in the SDS-
PAGE analysis, the low grafting with one PEG block per PEI displayed effective 
reduction in interaction of polycation DNA complexes with serum proteins. It is likely 
that protein binding to polycation DNA complexes reduce the zeta potential, thus 
resulting in aggregation of the complexes and/or affecting electrostatic interaction of the 
complexes with negatively charged cell membrane. In the study, it was also observed that 
the low degree of PEGylation could significantly reduce the interaction between serum 
protein and polycation DNA complexes in cultured cells. 
In the current study, PEG-PEI (1) was a more qualified candidate than PEI 
homopolymer in mediating transgene expression. As PEG blocks increased per PEI, 
transfection efficacy decreased. Another finding in this study was a higher N/P ratio was 
necessary for a significant transgene expression, especially for those copolymers with a 
higher degree of PEGylation. For instance, PEG-PEI (14.5) displayed a relatively high 
transgene expression at N/P ratios ranging from 40 to 70. In the animal experiments, the 
peak of transgene expression reached by PEG-PEI (1) at the N/P ratio of 30. This is also 
consistent with the recent report (Petersen et al., 2002b), which showed at N/P ratio of 50 
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PEG-PEI complexes showed higher transfection efficacy in the in vitro experiments than 
that mediated by PEI homopolymer. PEG grafting, ever at very low degrees, may 
considerably reduce the surface charges of the complexes (Petersen et al., 2002b). For 
binding to negatively charged cell membranes, net positive charge of complexes is 
required. A high N/P ratio may help to keep surface charges of complexes after 
PEGylation. Also, excess positive charges may protect PEI DNA complexes from 
aggregation under physiological condition (Yang et al., 1990), facilitating cellular uptake 
of the complexes. 
In summary, the feasibility of PEGylated PEI mediated repetitive administration 
of DNA/polymer complexes into the spinal cord through lumbar intrathecal injection was 
achieved. A prolonged transgene expression at a significant level persisted for up to 6 
weeks after 3 repeated dosing. Advantages of this method in spinal cord gene therapy 
include minimal damage to neural tissues, flexibility in controlling the therapeutic period, 
and possibility of achieving widespread gene expression. It also suggested that a low 
degree of PEGylation would be capable of altering immune stimulatory effects of CpG 
motifs in plasmid DNA. Further studies are needed to identify whether it is enough to 
reduce effects of immune inhibitory response upon gene expression. 
Recently, many therapeutic genes have been delivered to protect against 
neurodegenerative disease (Bowers et al., 1997; Raymon et al., 1997), instead of 
therapeutic proteins. For example, GDNF and BDNF were delivered to nigrostriatal 
system to protect the DA neurons in the Parkinsons disease animal model (Bohn, 1999). 
Strategies were also employed to enhance regeneration in the spinal cord injury by 
transfecting neurotrophic factors genes into the spinal cord or subarachnoid space (Bohn, 
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1999; Blesch et al., 1999; Schnell et al., 1994; Tuszynski et al., 1996). The advantage of 
the gene therapy method is that it can provide a localized source of trophic factors at the 
site of the cell soma to stimulate neuronal survival and possibly axon growth (Ye et al., 
1997; Blesch et al., 2002). At this point, PEGlyation PEI may be one of the promising 
candidates to provide a localized source of trophic factors at the site of the cell soma to 
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